- Novo Nordisk wins FDA label expansion for Wegovy against liver disease MASH Seeking Alpha
- Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH Reuters
- Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis PR Newswire
- Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH Yahoo Finance
- Novo Nordisk’s obesity drug Wegovy cleared to treat MASH statnews.com
Source link